Plasma Derived Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Plasma Derived Medicine is any therapeutic substance prepared from human blood.

The global market for Plasma Derived Medicine was estimated to be worth US$ 2291.1 million in 2023 and is forecast to a readjusted size of US$ 3847.1 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030

Plasma Derived Medicine Market Size

M= millions and B=billions

North American market for Plasma Derived Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Plasma Derived Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Plasma Derived Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Plasma Derived Medicine include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and Shanghai RAAS, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma Derived Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Plasma Derived Medicine by region & country, by Type, and by Application.

The Plasma Derived Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Derived Medicine.

Market Segmentation

• Report Metric

• Details

• Report Title

• Plasma Derived Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Forecasted Market Size in 2030

• US$ 3847.1 million

• CAGR(2024-2030)

• 7.8%

• Market Size Available for Years

• 2019-2030

• Global Plasma Derived Medicine Companies Covered

• Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, Shanghai RAAS, China Biologic Products, Hualan Biological Engineering Inc., Beijing Tiantan Biological Products Corp, Pacific Shuanglin, Boya Bio-Pharmaceutical, Paisi Feike Biology Pharmacy Co., Ltd., Xinjiang Deyuan Bioengineering, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Shenzhen Weiguang, Shanxi Kangbao, Nanyue Biopharming Corporation Ltd

• Global Plasma Derived Medicine Market, by Region

• North America (U.S., Canada, Mexico)

  Europe (Germany, France, UK, Italy, etc.)

  Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

  South America (Brazil, etc.)

  Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

• Global Plasma Derived Medicine Market, Segment by Type

• Albumin

  Immune Globulin

  Coagulation Factor

  Others

• Global Plasma Derived Medicine Market, Segment by Application

• Bleeding Wound

  Immunodeficiency

  HBV

  Tetanus

  Rabies

  Hemophilia

  Others

• Forecast Units

• USD million in value

• Report Coverage

• Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Plasma Derived Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Plasma Derived Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Plasma Derived Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Plasma Derived Medicine Product Introduction
    1.2 Global Plasma Derived Medicine Market Size Forecast
        1.2.1 Global Plasma Derived Medicine Sales Value (2019-2030)
        1.2.2 Global Plasma Derived Medicine Sales Volume (2019-2030)
        1.2.3 Global Plasma Derived Medicine Sales Price (2019-2030)
    1.3 Plasma Derived Medicine Market Trends & Drivers
        1.3.1 Plasma Derived Medicine Industry Trends
        1.3.2 Plasma Derived Medicine Market Drivers & Opportunity
        1.3.3 Plasma Derived Medicine Market Challenges
        1.3.4 Plasma Derived Medicine Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Plasma Derived Medicine Players Revenue Ranking (2023)
    2.2 Global Plasma Derived Medicine Revenue by Company (2019-2024)
    2.3 Global Plasma Derived Medicine Players Sales Volume Ranking (2023)
    2.4 Global Plasma Derived Medicine Sales Volume by Company Players (2019-2024)
    2.5 Global Plasma Derived Medicine Average Price by Company (2019-2024)
    2.6 Key Manufacturers Plasma Derived Medicine Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Plasma Derived Medicine Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Plasma Derived Medicine
    2.9 Plasma Derived Medicine Market Competitive Analysis
        2.9.1 Plasma Derived Medicine Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Plasma Derived Medicine Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Albumin
        3.1.2 Immune Globulin
        3.1.3 Coagulation Factor
        3.1.4 Others
    3.2 Global Plasma Derived Medicine Sales Value by Type
        3.2.1 Global Plasma Derived Medicine Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Plasma Derived Medicine Sales Value, by Type (2019-2030)
        3.2.3 Global Plasma Derived Medicine Sales Value, by Type (%) (2019-2030)
    3.3 Global Plasma Derived Medicine Sales Volume by Type
        3.3.1 Global Plasma Derived Medicine Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Plasma Derived Medicine Sales Volume, by Type (2019-2030)
        3.3.3 Global Plasma Derived Medicine Sales Volume, by Type (%) (2019-2030)
    3.4 Global Plasma Derived Medicine Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Bleeding Wound
        4.1.2 Immunodeficiency
        4.1.3 HBV
        4.1.4 Tetanus
        4.1.5 Rabies
        4.1.6 Hemophilia
        4.1.7 Others
    4.2 Global Plasma Derived Medicine Sales Value by Application
        4.2.1 Global Plasma Derived Medicine Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Plasma Derived Medicine Sales Value, by Application (2019-2030)
        4.2.3 Global Plasma Derived Medicine Sales Value, by Application (%) (2019-2030)
    4.3 Global Plasma Derived Medicine Sales Volume by Application
        4.3.1 Global Plasma Derived Medicine Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Plasma Derived Medicine Sales Volume, by Application (2019-2030)
        4.3.3 Global Plasma Derived Medicine Sales Volume, by Application (%) (2019-2030)
    4.4 Global Plasma Derived Medicine Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Plasma Derived Medicine Sales Value by Region
        5.1.1 Global Plasma Derived Medicine Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Plasma Derived Medicine Sales Value by Region (2019-2024)
        5.1.3 Global Plasma Derived Medicine Sales Value by Region (2025-2030)
        5.1.4 Global Plasma Derived Medicine Sales Value by Region (%), (2019-2030)
    5.2 Global Plasma Derived Medicine Sales Volume by Region
        5.2.1 Global Plasma Derived Medicine Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Plasma Derived Medicine Sales Volume by Region (2019-2024)
        5.2.3 Global Plasma Derived Medicine Sales Volume by Region (2025-2030)
        5.2.4 Global Plasma Derived Medicine Sales Volume by Region (%), (2019-2030)
    5.3 Global Plasma Derived Medicine Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Plasma Derived Medicine Sales Value, 2019-2030
        5.4.2 North America Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Plasma Derived Medicine Sales Value, 2019-2030
        5.5.2 Europe Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Plasma Derived Medicine Sales Value, 2019-2030
        5.6.2 Asia Pacific Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Plasma Derived Medicine Sales Value, 2019-2030
        5.7.2 South America Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Plasma Derived Medicine Sales Value, 2019-2030
        5.8.2 Middle East & Africa Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Plasma Derived Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Plasma Derived Medicine Sales Value
        6.2.1 Key Countries/Regions Plasma Derived Medicine Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Plasma Derived Medicine Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Plasma Derived Medicine Sales Value, 2019-2030
        6.3.2 United States Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Plasma Derived Medicine Sales Value, 2019-2030
        6.4.2 Europe Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Plasma Derived Medicine Sales Value, 2019-2030
        6.5.2 China Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Plasma Derived Medicine Sales Value, 2019-2030
        6.6.2 Japan Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Plasma Derived Medicine Sales Value, 2019-2030
        6.7.2 South Korea Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Plasma Derived Medicine Sales Value, 2019-2030
        6.8.2 Southeast Asia Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Plasma Derived Medicine Sales Value, 2019-2030
        6.9.2 India Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Plasma Derived Medicine Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Takeda
        7.1.1 Takeda Company Information
        7.1.2 Takeda Introduction and Business Overview
        7.1.3 Takeda Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Takeda Plasma Derived Medicine Product Offerings
        7.1.5 Takeda Recent Development
    7.2 CSL
        7.2.1 CSL Company Information
        7.2.2 CSL Introduction and Business Overview
        7.2.3 CSL Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 CSL Plasma Derived Medicine Product Offerings
        7.2.5 CSL Recent Development
    7.3 Grifols
        7.3.1 Grifols Company Information
        7.3.2 Grifols Introduction and Business Overview
        7.3.3 Grifols Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Grifols Plasma Derived Medicine Product Offerings
        7.3.5 Grifols Recent Development
    7.4 Octapharma
        7.4.1 Octapharma Company Information
        7.4.2 Octapharma Introduction and Business Overview
        7.4.3 Octapharma Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Octapharma Plasma Derived Medicine Product Offerings
        7.4.5 Octapharma Recent Development
    7.5 Kedrion
        7.5.1 Kedrion Company Information
        7.5.2 Kedrion Introduction and Business Overview
        7.5.3 Kedrion Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Kedrion Plasma Derived Medicine Product Offerings
        7.5.5 Kedrion Recent Development
    7.6 LFB Group
        7.6.1 LFB Group Company Information
        7.6.2 LFB Group Introduction and Business Overview
        7.6.3 LFB Group Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 LFB Group Plasma Derived Medicine Product Offerings
        7.6.5 LFB Group Recent Development
    7.7 Biotest
        7.7.1 Biotest Company Information
        7.7.2 Biotest Introduction and Business Overview
        7.7.3 Biotest Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Biotest Plasma Derived Medicine Product Offerings
        7.7.5 Biotest Recent Development
    7.8 BPL
        7.8.1 BPL Company Information
        7.8.2 BPL Introduction and Business Overview
        7.8.3 BPL Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 BPL Plasma Derived Medicine Product Offerings
        7.8.5 BPL Recent Development
    7.9 Shanghai RAAS
        7.9.1 Shanghai RAAS Company Information
        7.9.2 Shanghai RAAS Introduction and Business Overview
        7.9.3 Shanghai RAAS Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Shanghai RAAS Plasma Derived Medicine Product Offerings
        7.9.5 Shanghai RAAS Recent Development
    7.10 China Biologic Products
        7.10.1 China Biologic Products Company Information
        7.10.2 China Biologic Products Introduction and Business Overview
        7.10.3 China Biologic Products Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 China Biologic Products Plasma Derived Medicine Product Offerings
        7.10.5 China Biologic Products Recent Development
    7.11 Hualan Biological Engineering Inc.
        7.11.1 Hualan Biological Engineering Inc. Company Information
        7.11.2 Hualan Biological Engineering Inc. Introduction and Business Overview
        7.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Offerings
        7.11.5 Hualan Biological Engineering Inc. Recent Development
    7.12 Beijing Tiantan Biological Products Corp
        7.12.1 Beijing Tiantan Biological Products Corp Company Information
        7.12.2 Beijing Tiantan Biological Products Corp Introduction and Business Overview
        7.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Offerings
        7.12.5 Beijing Tiantan Biological Products Corp Recent Development
    7.13 Pacific Shuanglin
        7.13.1 Pacific Shuanglin Company Information
        7.13.2 Pacific Shuanglin Introduction and Business Overview
        7.13.3 Pacific Shuanglin Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Pacific Shuanglin Plasma Derived Medicine Product Offerings
        7.13.5 Pacific Shuanglin Recent Development
    7.14 Boya Bio-Pharmaceutical
        7.14.1 Boya Bio-Pharmaceutical Company Information
        7.14.2 Boya Bio-Pharmaceutical Introduction and Business Overview
        7.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Offerings
        7.14.5 Boya Bio-Pharmaceutical Recent Development
    7.15 Paisi Feike Biology Pharmacy Co., Ltd.
        7.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
        7.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Introduction and Business Overview
        7.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Offerings
        7.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
    7.16 Xinjiang Deyuan Bioengineering
        7.16.1 Xinjiang Deyuan Bioengineering Company Information
        7.16.2 Xinjiang Deyuan Bioengineering Introduction and Business Overview
        7.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.16.4 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Offerings
        7.16.5 Xinjiang Deyuan Bioengineering Recent Development
    7.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
        7.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
        7.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Introduction and Business Overview
        7.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Offerings
        7.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
    7.18 Shenzhen Weiguang
        7.18.1 Shenzhen Weiguang Company Information
        7.18.2 Shenzhen Weiguang Introduction and Business Overview
        7.18.3 Shenzhen Weiguang Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.18.4 Shenzhen Weiguang Plasma Derived Medicine Product Offerings
        7.18.5 Shenzhen Weiguang Recent Development
    7.19 Shanxi Kangbao
        7.19.1 Shanxi Kangbao Company Information
        7.19.2 Shanxi Kangbao Introduction and Business Overview
        7.19.3 Shanxi Kangbao Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.19.4 Shanxi Kangbao Plasma Derived Medicine Product Offerings
        7.19.5 Shanxi Kangbao Recent Development
    7.20 Nanyue Biopharming Corporation Ltd
        7.20.1 Nanyue Biopharming Corporation Ltd Company Information
        7.20.2 Nanyue Biopharming Corporation Ltd Introduction and Business Overview
        7.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
        7.20.4 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Offerings
        7.20.5 Nanyue Biopharming Corporation Ltd Recent Development

 8 Industry Chain Analysis
    8.1 Plasma Derived Medicine Industrial Chain
    8.2 Plasma Derived Medicine Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Plasma Derived Medicine Sales Model
        8.5.2 Sales Channel
        8.5.3 Plasma Derived Medicine Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Plasma Derived Medicine Market Trends
    Table 2. Plasma Derived Medicine Market Drivers & Opportunity
    Table 3. Plasma Derived Medicine Market Challenges
    Table 4. Plasma Derived Medicine Market Restraints
    Table 5. Global Plasma Derived Medicine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Plasma Derived Medicine Revenue Market Share by Company (2019-2024)
    Table 7. Global Plasma Derived Medicine Sales Volume by Company (2019-2024) & (K Bottles)
    Table 8. Global Plasma Derived Medicine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Plasma Derived Medicine Price by Company (2019-2024) & (USD/Bottle)
    Table 10. Key Manufacturers Plasma Derived Medicine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Plasma Derived Medicine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Plasma Derived Medicine
    Table 13. Global Plasma Derived Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Plasma Derived Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Plasma Derived Medicine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Plasma Derived Medicine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Plasma Derived Medicine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Plasma Derived Medicine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Plasma Derived Medicine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Bottles)
    Table 22. Global Plasma Derived Medicine Sales Volume by Type (2019-2024) & (K Bottles)
    Table 23. Global Plasma Derived Medicine Sales Volume by Type (2025-2030) & (K Bottles)
    Table 24. Global Plasma Derived Medicine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Plasma Derived Medicine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Plasma Derived Medicine Price by Type (2019-2024) & (USD/Bottle)
    Table 27. Global Plasma Derived Medicine Price by Type (2025-2030) & (USD/Bottle)
    Table 28. Global Plasma Derived Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Plasma Derived Medicine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Plasma Derived Medicine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Plasma Derived Medicine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Plasma Derived Medicine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Plasma Derived Medicine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Bottles)
    Table 34. Global Plasma Derived Medicine Sales Volume by Application (2019-2024) & (K Bottles)
    Table 35. Global Plasma Derived Medicine Sales Volume by Application (2025-2030) & (K Bottles)
    Table 36. Global Plasma Derived Medicine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Plasma Derived Medicine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Plasma Derived Medicine Price by Application (2019-2024) & (USD/Bottle)
    Table 39. Global Plasma Derived Medicine Price by Application (2025-2030) & (USD/Bottle)
    Table 40. Global Plasma Derived Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Plasma Derived Medicine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Plasma Derived Medicine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Plasma Derived Medicine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Plasma Derived Medicine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Plasma Derived Medicine Sales Volume by Region (K Bottles): 2019 VS 2023 VS 2030
    Table 46. Global Plasma Derived Medicine Sales Volume by Region (2019-2024) & (K Bottles)
    Table 47. Global Plasma Derived Medicine Sales Volume by Region (2025-2030) & (K Bottles)
    Table 48. Global Plasma Derived Medicine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Plasma Derived Medicine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Plasma Derived Medicine Average Price by Region (2019-2024) & (USD/Bottle)
    Table 51. Global Plasma Derived Medicine Average Price by Region (2025-2030) & (USD/Bottle)
    Table 52. Key Countries/Regions Plasma Derived Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Plasma Derived Medicine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Plasma Derived Medicine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Plasma Derived Medicine Sales Volume, (2019-2024) & (K Bottles)
    Table 56. Key Countries/Regions Plasma Derived Medicine Sales Volume, (2025-2030) & (K Bottles)
    Table 57. Takeda Company Information
    Table 58. Takeda Introduction and Business Overview
    Table 59. Takeda Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 60. Takeda Plasma Derived Medicine Product Offerings
    Table 61. Takeda Recent Development
    Table 62. CSL Company Information
    Table 63. CSL Introduction and Business Overview
    Table 64. CSL Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 65. CSL Plasma Derived Medicine Product Offerings
    Table 66. CSL Recent Development
    Table 67. Grifols Company Information
    Table 68. Grifols Introduction and Business Overview
    Table 69. Grifols Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 70. Grifols Plasma Derived Medicine Product Offerings
    Table 71. Grifols Recent Development
    Table 72. Octapharma Company Information
    Table 73. Octapharma Introduction and Business Overview
    Table 74. Octapharma Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 75. Octapharma Plasma Derived Medicine Product Offerings
    Table 76. Octapharma Recent Development
    Table 77. Kedrion Company Information
    Table 78. Kedrion Introduction and Business Overview
    Table 79. Kedrion Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 80. Kedrion Plasma Derived Medicine Product Offerings
    Table 81. Kedrion Recent Development
    Table 82. LFB Group Company Information
    Table 83. LFB Group Introduction and Business Overview
    Table 84. LFB Group Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 85. LFB Group Plasma Derived Medicine Product Offerings
    Table 86. LFB Group Recent Development
    Table 87. Biotest Company Information
    Table 88. Biotest Introduction and Business Overview
    Table 89. Biotest Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 90. Biotest Plasma Derived Medicine Product Offerings
    Table 91. Biotest Recent Development
    Table 92. BPL Company Information
    Table 93. BPL Introduction and Business Overview
    Table 94. BPL Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 95. BPL Plasma Derived Medicine Product Offerings
    Table 96. BPL Recent Development
    Table 97. Shanghai RAAS Company Information
    Table 98. Shanghai RAAS Introduction and Business Overview
    Table 99. Shanghai RAAS Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 100. Shanghai RAAS Plasma Derived Medicine Product Offerings
    Table 101. Shanghai RAAS Recent Development
    Table 102. China Biologic Products Company Information
    Table 103. China Biologic Products Introduction and Business Overview
    Table 104. China Biologic Products Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 105. China Biologic Products Plasma Derived Medicine Product Offerings
    Table 106. China Biologic Products Recent Development
    Table 107. Hualan Biological Engineering Inc. Company Information
    Table 108. Hualan Biological Engineering Inc. Introduction and Business Overview
    Table 109. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 110. Hualan Biological Engineering Inc. Plasma Derived Medicine Product Offerings
    Table 111. Hualan Biological Engineering Inc. Recent Development
    Table 112. Beijing Tiantan Biological Products Corp Company Information
    Table 113. Beijing Tiantan Biological Products Corp Introduction and Business Overview
    Table 114. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 115. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Offerings
    Table 116. Beijing Tiantan Biological Products Corp Recent Development
    Table 117. Pacific Shuanglin Company Information
    Table 118. Pacific Shuanglin Introduction and Business Overview
    Table 119. Pacific Shuanglin Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 120. Pacific Shuanglin Plasma Derived Medicine Product Offerings
    Table 121. Pacific Shuanglin Recent Development
    Table 122. Boya Bio-Pharmaceutical Company Information
    Table 123. Boya Bio-Pharmaceutical Introduction and Business Overview
    Table 124. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 125. Boya Bio-Pharmaceutical Plasma Derived Medicine Product Offerings
    Table 126. Boya Bio-Pharmaceutical Recent Development
    Table 127. Paisi Feike Biology Pharmacy Co., Ltd. Company Information
    Table 128. Paisi Feike Biology Pharmacy Co., Ltd. Introduction and Business Overview
    Table 129. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 130. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Offerings
    Table 131. Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
    Table 132. Xinjiang Deyuan Bioengineering Company Information
    Table 133. Xinjiang Deyuan Bioengineering Introduction and Business Overview
    Table 134. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 135. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Offerings
    Table 136. Xinjiang Deyuan Bioengineering Recent Development
    Table 137. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
    Table 138. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 139. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 140. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Offerings
    Table 141. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
    Table 142. Shenzhen Weiguang Company Information
    Table 143. Shenzhen Weiguang Introduction and Business Overview
    Table 144. Shenzhen Weiguang Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 145. Shenzhen Weiguang Plasma Derived Medicine Product Offerings
    Table 146. Shenzhen Weiguang Recent Development
    Table 147. Shanxi Kangbao Company Information
    Table 148. Shanxi Kangbao Introduction and Business Overview
    Table 149. Shanxi Kangbao Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 150. Shanxi Kangbao Plasma Derived Medicine Product Offerings
    Table 151. Shanxi Kangbao Recent Development
    Table 152. Nanyue Biopharming Corporation Ltd Company Information
    Table 153. Nanyue Biopharming Corporation Ltd Introduction and Business Overview
    Table 154. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 155. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Offerings
    Table 156. Nanyue Biopharming Corporation Ltd Recent Development
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Plasma Derived Medicine Downstream Customers
    Table 160. Plasma Derived Medicine Distributors List
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Plasma Derived Medicine Product Picture
    Figure 2. Global Plasma Derived Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Plasma Derived Medicine Sales Volume (2019-2030) & (K Bottles)
    Figure 5. Global Plasma Derived Medicine Sales Price (2019-2030) & (USD/Bottle)
    Figure 6. Plasma Derived Medicine Report Years Considered
    Figure 7. Global Plasma Derived Medicine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Plasma Derived Medicine Players Sales Volume Ranking (2023) & (K Bottles)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Plasma Derived Medicine Revenue in 2023
    Figure 10. Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Albumin Picture
    Figure 12. Immune Globulin Picture
    Figure 13. Coagulation Factor Picture
    Figure 14. Others Picture
    Figure 15. Global Plasma Derived Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Plasma Derived Medicine Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Plasma Derived Medicine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Bottles)
    Figure 18. Global Plasma Derived Medicine Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Plasma Derived Medicine Price by Type (2019-2030) & (USD/Bottle)
    Figure 20. Product Picture of Bleeding Wound
    Figure 21. Product Picture of Immunodeficiency
    Figure 22. Product Picture of HBV
    Figure 23. Product Picture of Tetanus
    Figure 24. Product Picture of Rabies
    Figure 25. Product Picture of Hemophilia
    Figure 26. Product Picture of Others
    Figure 27. Global Plasma Derived Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 28. Global Plasma Derived Medicine Sales Value Market Share by Application, 2023 & 2030
    Figure 29. Global Plasma Derived Medicine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Bottles)
    Figure 30. Global Plasma Derived Medicine Sales Volume Market Share by Application, 2023 & 2030
    Figure 31. Global Plasma Derived Medicine Price by Application (2019-2030) & (USD/Bottle)
    Figure 32. North America Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 33. North America Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 34. Europe Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 35. Europe Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 36. Asia Pacific Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 37. Asia Pacific Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 38. South America Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 39. South America Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 40. Middle East & Africa Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 42. Key Countries/Regions Plasma Derived Medicine Sales Value (%), (2019-2030)
    Figure 43. Key Countries/Regions Plasma Derived Medicine Sales Volume (%), (2019-2030)
    Figure 44. United States Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 45. United States Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 46. United States Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 47. Europe Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Europe Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 49. Europe Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 50. China Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 51. China Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 52. China Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 53. Japan Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Japan Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 55. Japan Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 56. South Korea Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 57. South Korea Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 58. South Korea Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 59. Southeast Asia Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 60. Southeast Asia Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 61. Southeast Asia Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 62. India Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 63. India Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 64. India Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 65. Plasma Derived Medicine Industrial Chain
    Figure 66. Plasma Derived Medicine Manufacturing Cost Structure
    Figure 67. Channels of Distribution (Direct Sales, and Distribution)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed

Plasma Derived Medicine is any therapeutic substance prepared from human blood.

The global market for Plasma Derived Medicine was estimated to be worth US$ 2291.1 million in 2023 and is forecast to a readjusted size of US$ 3847.1 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030

North American market for Plasma Derived Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Plasma Derived Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Plasma Derived Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Plasma Derived Medicine include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and Shanghai RAAS, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma Derived Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Plasma Derived Medicine by region & country, by Type, and by Application.

The Plasma Derived Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Derived Medicine.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Plasma Derived Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Plasma Derived Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Plasma Derived Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.